Compounds > kp 136
Page last updated: 2024-12-08

kp 136

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

KP 136: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID166484
SCHEMBL ID6439140
SCHEMBL ID15660386
MeSH IDM0150420

Synonyms (18)

Synonym
al-136
kp-136
kp 136
al 136
2h-1-benzopyran-2-one, 8-(hexyloxy)-3-(1h-tetrazol-5-yl)-
8-n-hexyloxy-3-(1h-tetrazol-5-yl)coumarin
8-(hexyloxy)-3-(1h-tetrazol-5-yl)-2h-1-benzopyran-2-one
76239-32-2
8-hexoxy-3-(2h-tetrazol-5-yl)chromen-2-one
2h-1-benzopyran-2-one,8-(hexyloxy)-3-(2h-tetrazol-5-yl)-
DTXSID90227087
al136 ,
SCHEMBL6439140
SCHEMBL15660386
CS-7226
kp136
HY-U00168
AKOS040741917
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
histamine
[no description available]		1.9710aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
cromolyn sodium
Cromolyn Sodium: A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.. disodium cromoglycate : An organic sodium salt that is the disodium salt of cromoglycic acid.		2.6630organic sodium saltanti-asthmatic drug;
drug allergen
calcimycin
Calcimycin: An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.		1.9710benzoxazole
ConditionIndicatedRelationship StrengthStudiesTrials
Polyarthritis
[description not available]		01.9710
Adjuvant Arthritis
[description not available]		01.9710
Arthus Phenomenon
[description not available]		01.9710
Anasarca
[description not available]		01.9710
Extravascular Hemolysis
[description not available]		02.3820
Delayed Hypersensitivity
[description not available]		01.9710
Atopic Hypersensitivity
[description not available]		01.9710
Arthritis
Acute or chronic inflammation of JOINTS.		01.9710
Edema
Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.		01.9710
Hemolysis
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.		02.3820
Asthma, Bronchial
[description not available]		02.3820
Asthma
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).		02.3820
Muscle Relaxation
That phase of a muscle twitch during which a muscle returns to a resting position.		01.9710
Allergic Reaction
[description not available]		01.9710
Hypersensitivity
Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.		01.9710